Search
Search
Close this search box.

South Dakota to Vote on Cannabis Legalization for 3rd Time

Adult-use cannabis legalization is set to go to the ballot box for the third time in South Dakota this November.

Earlier this week, Monae Johnson, the Secretary of State, waved through a measure that will enable South Dakotan’s vote on the proposal during the general election, the Associated Press reported. 

It comes after a petition to push through the ballot received over 22,000 signatures from registered voters, comfortably surpassing the 17,508 signatures required.

Should South Dakota vote to pass the bill, adult-use cannabis consumption would be made legal for people 21 and older.

While it is understood that the bill will not allow for a commercial framework, it would legalize possession of up to 2 ounces of cannabis flower, 16 grams of concentrates, and the home cultivation of up to six plants.

In 2020, South Dakota made history as the first state where voters approved both recreational and medical marijuana legalization simultaneously. However, the state Supreme Court invalidated the recreational measure after a challenge by Governor Kristi Noem, citing a technicality.

In 2022, voters rejected another initiative that would have allowed adults to possess and use home-grown cannabis but did not establish a recreational cannabis market.

Matthew Schweich, Director of South Dakotans for Better Marijuana Laws, expressed optimism, saying, “We are very pleased that we’ve qualified for the ballot and are extremely thankful to everyone who signed our petitions, our volunteers, our staff, and our supporters. We look forward to being on the ballot in November and we’re confident we can win again and restore the will of the people of South Dakota.”

Paul Armentano, NORML’s Deputy Director, also highlighted the strong grassroots support for legalization, stating, “It is a testament to the grassroots support that exists in favor of legalization in South Dakota that advocates were successful in their effort to once again place the legalization question before voters.”

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?